The Miller School of Medicine has been awarded a $470,000 grant to be part of a multicenter clinical trial to evaluate an emerging treatment option for benign prostatic hyperplasia (BPH), an enlarged prostate, which affects more than 50 percent of men over age 50. With this approval from the Food and Drug Administration, the University of Miami will be one of just ten sites in the nation and the second site in South Florida.
With the cutting of a ceremonial, bright orange ribbon, the leadership and faculty of the University of Miami Miller School of Medicine officially unveiled the new Sylvester Comprehensive Cancer Center Interventional Radiology Clinic, and dedicated the new Philip and Linda Corey Patient Reception area.
A multidisciplinary group of Miller School of Medicine researchers, collaborating with investigators from the University of Munich and the University of Pittsburgh, has identified 10 complementing morphologic and physiologic measurements that better characterize a neurological disorder known as Chiari Malformation Type I (CMI) and are likely to improve identification of appropriate surgical candidates.
The National Institutes of Health/National Cancer Institute has awarded researchers at the Miller School of Medicine $3 million in funding over five years to explore breakthrough uses of MRI imaging and genetic signatures in managing prostate cancer diagnosis and treatment.
A collaborative report encompassing three Miller School and UHealth departments highlights a new technique for surgically accessing sensory nerves and neuromas. Published online ahead of print in the journal Neurosurgery, the report is the first to illustrate the use of pre-operative ultrasound combined with specialized needle placement to localize the infrapatellar branches of the saphenous nerve.